Treatment progress of intrahepatic cholangiocarcinoma
10.3760/cma.j.issn.1673-422X.2016.01.017
- VernacularTitle:肝内胆管细胞癌的治疗进展
- Author:
Mengchao LUO
;
Chaofeng DING
;
Jian WU
;
Shusen ZHENG
- Publication Type:Journal Article
- Keywords:
Bile ducts,intrahepatic;
Bile duct neoplasms;
Therapeutics;
Prognosis
- From:
Journal of International Oncology
2016;43(1):60-63
- CountryChina
- Language:Chinese
-
Abstract:
Surgical resection is still the mainstay for treatment of intrahepatic cholangiocarcinoma (ICC).Gemcitabine and cisplatin is a systemic therapy practice standard for patients with non-resectable ICC.Neoadjuvant therapy with liver transplantation may be a new therapeutic option for patients with ICC.In addition, radiotherapy, hepatic intra-arterial therapy, ablation therapy and molecular targeted therapy are important components of comprehensive therapy for ICC.
